Europe is taking further steps to strengthen its bioeconomy and address one of the persistent challenges facing innovative companies: moving from research and demonstration to commercial scale.
On 10 June, the European Commission launched three complementary initiatives to support implementation of the EU Bioeconomy Strategy: the Bio-based Europe Alliance (BEA), the Bioeconomy Investment Deployment Group (BIDG) and a new Expert Group on Bioeconomy.
Together, the initiatives focus on three important dimensions of a stronger European bioeconomy: connecting innovation with market demand, improving access to finance and supporting implementation at national and regional level.
Bridging the scale-up gap
Europe has invested significantly in research, innovation and demonstration in the bio-based sector. However, promising companies can still face difficulties when moving towards full commercial deployment.
The new Bio-based Europe Alliance aims to address part of this gap by connecting producers of bio-based materials, products and technologies with major European buyers. The initiative seeks to create stronger market signals and mobilise corporate demand, with a target of €10 billion in corporate offtake commitments by 2030.
At the same time, the Bioeconomy Investment Deployment Group brings together commercial banks, national promotional banks, venture capital funds and institutional investors to strengthen awareness of investment opportunities and help mobilise public and private finance for the sector.
The role of regional ecosystems
The third element is particularly relevant to Europe’s innovation ecosystems. The new Expert Group on Bioeconomy will support Member States in implementing the EU Bioeconomy Strategy and contribute to the development of national and regional bioeconomy strategies.
This highlights the importance of connecting European-level policy with the organisations, companies, research institutions and innovation ecosystems operating at regional level.
For clusters and networks across Europe, the challenge is increasingly about building the connections that allow promising technologies to access expertise, investment, industrial partners and markets.
Building a more connected European bioeconomy
The latest initiatives point towards a broader approach to European competitiveness: supporting innovation is not only about funding research, but also about creating the conditions for technologies and companies to grow within Europe.
For the European life sciences ecosystem, stronger links between research, industry, finance and regional innovation ecosystems will be an important part of turning scientific excellence into sustainable economic and societal impact.
